Wellington Management Group LLP purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 121,769 shares of the exchange traded fund’s stock, valued at approximately $19,270,000. Wellington Management Group LLP owned about 0.19% of SPDR S&P Biotech ETF as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Axiom Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth $26,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF in the 1st quarter worth $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $27,000. Intesa Sanpaolo Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $30,000. Finally, SHP Wealth Management bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $31,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA XBI opened at $163.81 on Monday. The business has a 50-day moving average of $158.18 and a 200-day moving average of $140.63. The stock has a market capitalization of $10.70 billion, a price-to-earnings ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a fifty-two week low of $92.64 and a fifty-two week high of $169.89.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
